Find my Forest Laboratories Inc 401(k) plan

Forest Laboratories Inc. is a global pharmaceutical company headquartered in New York City founded in 1956 by Howard Solomon. It is primarily focused on developing, licensing, and marketing drugs that target central nervous system disorders and other medical conditions. Forest’s products address unmet needs in mental health, gastroenterology, cardiovascular diseases, respiratory illnesses, women’s healthcare and metabolic diseasemarkets. The key markets are the United States ($1.72B revenue), Europe ($206M) and Japan ($168M). Forest focuses on highly focused research investments to develop innovative medicines for patients with CNS-related (Central Nervous System Disorders) conditions such as depression/anxiety related cognitive dysfunctioning disorders; Alzheimer’s Disease; Schizophrenia/Psychotic Disorders; gastric/intestinal disorders; diabetes; hypertension/cholesterol-related disorders; pain medications; Parkinson’s Disease related symptoms management and cancer treatments. Today Forest has emerged as one of the leading innovators across multiple therapeutic categories.